Photo of Vijayshree Yadav, M.D., M.C.R., FANA, FAAN

Vijayshree Yadav M.D., M.C.R., FANA, FAAN

Dr. Yadav is a board certified neurologist who received her medical degree in 1995 from SN Medical College in Agra, India. She completed  her fellowship in neuroimmunology and multiple sclerosis at Oregon Health & Science University and Portland VA Medical Center in 2004. In 2004, she joined the OHSU MS Center and is an assistant professor in the Department of Neurology. She received her masters in clinical research in 2008 and in 2010 was appointed clinical medical director of the OHSU MS Center.

Dr. Yadav's research interests include complementary and alternative treatment options for multiple sclerosis including dietary and  life style changes as well as supplements such as lipoic acid. She has published several peer reviewed journal articles and presented her research at national and international meetings.


  • M.D., SN Medical College, Agra India 1995
  • Residency:

    • Intern in internal medicine, Westlake Community Hospital, Melrose Park, IL, 1997
  • Fellowship:

    • Neuroimmunology and multiple sclerosis, Oregon Health & Science University and Portland VA Medical Center, 2004
  • Certifications:

    • American Board of Psychiatry and Neurology


  • "A highly immunogenic trivalent T cell receptor peptide vaccine for multiple sclerosis" Multiple Sclerosis October 2005
  • "Recombinant T-cell receptor ligand (RTL) for treatment of multiple sclerosis" Autoimmune Diseases  2012
  • "Lipoic acid" Endocrine, Metabolic and Immune Disorders - Drug Targets June 2008
  • "Cognitive impairment and MS" Current Neurology and Neuroscience Reports October 2011
  • "A randomized pilot study of naturopathic medicine in multiple sclerosis" Journal of Alternative and Complementary Medicine June 1 2008
  • "New disease-modifying therapies and new challenges for MS" Current Neurology and Neuroscience Reports October 2012
  • "Therapeutic vaccination with a trivalent T-cell receptor (TCR) peptide vaccine restores deficient FoxP3 expression and TCR recognition in subjects with multiple sclerosis" Immunology January 2008
  • "Apical Ballooning Resulting from Limbic Encephalitis" American Journal of Medicine June 2009
  • "The perceived benefit and satisfaction from conventional and complementary and alternative medicine (CAM) in people with multiple sclerosis" Complementary Therapies in Medicine December 2005
  • "Complementary and alternative medicine for the treatment of multiple sclerosis" Expert Review of Clinical Immunology May 2010
  • "Complementary and alternative treatments in multiple sclerosis"  December 1 2011
  • "Summary of evidence-based guideline" Neurology March 25 2014
  • "Alemtuzumab versus interferon beta-1a in early multiple sclerosis" Current Neurology and Neuroscience Reports  2009
  • "Lipoic acid in multiple sclerosis" Multiple Sclerosis April 2005
  • "Complementary and alternative medical therapies in multiple sclerosis - The American Academy of Neurology Guidelines" Clinical Therapeutics December 1 2014
  • "Treat patients with radiologically isolated syndrome when the MRI brain scan shows dissemination in time" Multiple Sclerosis  2012
  • "Lipoic acid attenuates inflammation via cAMP and protein kinase A signaling" PLoS One September 28 2010
  • "Omega-3 fatty acid supplementation decreases matrix metalloproteinase-9 production in relapsing-remitting multiple sclerosis," Prostaglandins Leukotrienes and Essential Fatty Acids February 2009
  • "Demographic and health-related factors associated with complementary and alternative medicine (CAM) use in multiple sclerosis" Multiple Sclerosis February 2006
  • "Complementary and alternative medicine" Current Neurology and Neuroscience Reports May 2006
  • "Memantine for cognitive impairment in multiple sclerosis" Multiple Sclerosis  2010
  • "Oral disease-modifying therapies for multiple sclerosis" Current Neurology and Neuroscience Reports September 2010
  • "Pharmacokinetic study of acid in multiple sclerosis" Multiple Sclerosis April 2010
  • "Perceived Stress in Multiple Sclerosis" Journal of Evidence-Based Integrative Medicine  2014
  • "The radiologically isolated syndrome revisited" Neurology February 22 2011
  • "Clinical trial of a formal group fatigue program in multiple sclerosis" Multiple Sclerosis  2010
  • "The effects of omega-3 fatty acids on matrix metalloproteinase-9 production and cell migration in human immune cells" Autoimmune Diseases  2011
  • "Use of Cannabinoids for Spasticity and Pain Management in MS" Current Treatment Options in Neurology January 1 2016
  • "Author response" Neurology October 1 2014
  • "Low-fat, plant-based diet in multiple sclerosis" Multiple Sclerosis and Related Disorders September 1 2016

Additional information

Edit profile